Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PF-06459988 |
Synonyms | |
Therapy Description |
PF-06459988 is a third-generation irreversible EGFR inhibitor that is selective towards mutant EGFR, including T790M, and demonstrates little activity towards wild-type EGFR (PMID: 23456430). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-06459988 | EGFR Inhibitor 3rd gen 26 | PF-06459988 is a third-generation irreversible EGFR inhibitor that is selective towards mutant EGFR, including T790M, and demonstrates little activity towards wild-type EGFR (PMID: 23456430). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|